Torrent Pharmaceuticals has launched bio similar Adalimumab, used for the treatment of auto immune disorders in India its under the brand name ‘Adfrar’. The company’s product will be available as pre-filled syringe of 40 mg. Adalimumab is a preferred therapy for the treatment of auto immune disorders and has wide applications for treatment of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis and plaque psoriasis among others. Autoimmune disorders are growing ailments and monoclonal antibodies (MAb’s) are becoming mainstay of treatment.
Company Profile : Torrent Pharmaceuticals Ltd
Leave a Reply